Australia markets close in 45 minutes

Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC)

MCE - MCE Delayed price. Currency in EUR
Add to watchlist
87.55+0.60 (+0.69%)
At close: 05:36PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
137,837
170,335
199,669
153,077
61,057
Depreciation & amortisation
25,141
24,331
22,871
21,364
19,593
Stock-based compensation
-
-
0
1,403
0
Change in working capital
-31,793
-34,448
-56,973
-64,034
-63,751
Inventory
-14,338
-29,294
-71,591
-23,427
-70,398
Other working capital
45,017
58,060
186,214
108,501
7,184
Other non-cash items
-1,369
-1,675
-3,825
-5,636
-1,072
Net cash provided by operating activities
104,283
113,247
237,602
149,441
46,876
Cash flows from investing activities
Investments in property, plant and equipment
-59,266
-55,187
-51,388
-40,940
-39,692
Acquisitions, net
-855
-600
0
-
-
Purchases of investments
-
0
-5,870
0
-
Sales/maturities of investments
168
88
20
0
-
Net cash used for investing activities
-56,350
-52,028
-57,154
-40,839
-39,625
Net change in cash
-128,377
-99,623
25,910
45,873
-14,264
Cash at beginning of period
141,462
124,945
99,035
53,162
67,426
Cash at end of period
13,085
25,322
124,945
99,035
53,162
Free cash flow
Operating cash flow
104,283
113,247
237,602
149,441
46,876
Capital expenditure
-59,266
-55,187
-51,388
-40,940
-39,692
Free cash flow
45,017
58,060
186,214
108,501
7,184